Actualités - IntegraGen

IN THE NEWS

NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

3 March 2021

Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset As provider of the bulk and single-cell RNA-seq libraries and sequencing, IntegraGen is proud of... Read More
BRIEF TECHNIQUE: LOW-PASS WHOLE GENOME SEQUENCING - GETTING MORE FROM LESS

9 October 2020

LP-WGS analysis of liquid biopsies (ctDNA) for oncology applications Background Analysis of circulating tumor DNA (ctDNA) offers great opportunities for cancer research and patient care. There are multiple... Read More
ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT "OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS" OF ONCODNA S.A.

September 16, 2020

This press release has been prepared and issued by OncoDNA S.A. in accordance with the provisions of Articles 231-27 1° and 2° and 231-28 of the French General... Read More

ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT "OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS" OF ONCODNA S.A.

September 16, 2020

This press release has been prepared and issued by OncoDNA S.A. pursuant to... Read More
COMBINED GENERAL MEETING

1 September 2020

IntegraGen's Combined Ordinary and Extraordinary General Meeting will be held on September 17 at 2 pm... Read More
WHAT'S NEW FOR MERCURY?

10 July 2020

Latest update: MERCURY™ v3.0 We are delighted to present the new version... Read More
AGREEMENT ON A FRIENDLY TAKEOVER BID BY ONCODNA FOR INTEGRAGEN

9 July 2020

Agreement to a friendly takeover bid initiated by ONCODNA for INTEGRAGEN at a price... Read More